Skip to main content
Patient Advocacy

Is Your Community Underrepresented in Clinical Trials? How Your Participation Can Help

Clinical trials need diversity to make sure treatments are safe and effective for a wide range of people.

Marisa Taylor KarasPatricia Pinto-Garcia, MD, MPH
Written by Marisa Taylor Karas | Reviewed by Patricia Pinto-Garcia, MD, MPH
Updated on April 29, 2025
Featuring June Y. Hou, MDReviewed by Patricia Pinto-Garcia, MD, MPH | April 29, 2025

In this video, learn why diversity in clinical trials for cancer treatment is so important, according to June Y. Hou, MD, Gynecologic Oncologist at Columbia University’s Irving Medical Center.

References

GoodRx Health has strict sourcing policies and relies on primary sources such as medical organizations, governmental agencies, academic institutions, and peer-reviewed scientific journals. Learn more about how we ensure our content is accurate, thorough, and unbiased by reading our editorial guidelines.

why trust our exports reliability shield

Why trust our experts?

Marisa Taylor Karas is a freelance journalist based in Brooklyn who has covered health, gender, and technology for 15 years. She previously worked at The Wall Street Journal, The Guardian, and Al Jazeera America, among other publications, and also served as managing editor of the Mellon Foundation in New York City.
Patricia Pinto-Garcia, MD, MPH, is a medical editor at GoodRx. She is a licensed, board-certified pediatrician with more than a decade of experience in academic medicine.

Was this page helpful?

Latest articles